The Global Low-Cost Airline Market to 2020

In terms of seat capacity, the global low cost carrier (LCC) industry is expanding. According to the International Air Transport Association (IATA), LCCs hold 26% share in Asia-Pacific, 54% in Southeast Asia, and 26% globally. More than 12 airlines started operating in Asia-Pacific during the period 2005-2015.

ar.png

The US is the largest market in the world in terms of revenues and seats sold. In 2015, its revenues stood at US$31.6 billion and the number of passengers carried totaled 216.6 million. Spain and the UK held second and third position in terms of seats sold, while Japan was the fastest-growing market at a CAGR of 33.7% during the historic period (2011-2015). Switzerland (90.6%) had the highest load factor in 2015, followed by France (90.5%) and Mexico (89.9%). In terms of revenue per passenger, New Zealand was the largest market while China was the fastest-growing market at a CAGR of 3.7% during the historic period.

Canadean’s latest report The Global Low-Cost Airline Market to 2020 provides detailed information on global low-cost airlines industry, analyzing market data and providing insights.

Report Information:
Price:
$3,450 (Single User License)
Published: Nov 2016
Publisher: Canadean
Report Format: electronic pdf

Advertisements

Strategic Trends in Private Equity and Venture Capital Funding for Healthcare

For PE firms and VC companies, capital commitments, also referred to as fundraising, are crucial to their business models; which require significant funds to be able to fund companies and provide mezzanine capital (a hybrid of debt and equity financing that is typically utilized to finance the expansion of operations of already established companies), and for PE firms to engage in buyouts. It is therefore important that these companies are able to raise adequate levels of capital from outside investors, to enable them to invest in emerging companies in various sectors of the economy.

main.png

The accumulating evidence of the decline in R&D productivity adds to the uncertainty associated with innovation in the healthcare industry, which in turn reduces the attractiveness of the field for investment. If investments from private equity and venture capital (VC) firms in the healthcare industry continue to decrease significantly, it could have serious and wide-ranging consequences not just in the healthcare sector, but in wider economies.

CBR Pharma Insight’s latest report Strategic Trends in Private Equity and Venture Capital Funding for Healthcare provides a comprehensive analysis on emerging investment trends within the healthcare industry. The report also includes forecasts for the outlook for PE and VC firms investing in the healthcare sector. VC investment in early-stage healthcare companies continues to decline, and has almost completely disappeared in certain countries.

Report Information
Price: $2,995 (Single User License)
Published: Nov – 2016
Publisher: CBR Pharma
Report Format: electronic pdf

Global Drug Delivery Technologies

Drug Delivery Technologies – An Overview

Drug delivery technologies are engineered technologies that deliver drugs to achieve a therapeutic effect. Advances in these technologies usually aim to increase the efficacy of the drug, improve drug absorption and decrease side effects. Drugs are administered via different routes, mechanisms, and carriers. The most common routes are oral and directly into the systemic circulation. Other non-invasive routes include topical and transmucosal delivery. Examples of transmucosal delivery include ocular, nasal, buccal, sublingual, vaginal and rectal delivery.

gbi sr.png

As shown in the above figure, some of the common carriers used for the delivery of a drug into the system are nucleic acid-based carriers, cell-based carriers, magnetic particles, nanoparticles-based carriers, polymer-based carriers and lipid-based carriers. Protein and peptide drugs are mostly delivered intravenously, as they are susceptible to degradation in the digestive tract.

CBR Pharma Insight’s latest report Global Drug Delivery Technologies – Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during the Forecast Period discusses the drug delivery technologies and trends in the market and the evolving business strategies being adopted and leveraged by companies globally. The ultimate goal of drug delivery research is to develop formulations and devices that can be used in clinical applications to treat various diseases.

Report Information
Price: $2,995 (Single User License)
Published: Nov – 2016
Publisher: CBR Pharma
Report Format: electronic pdf